Status:

UNKNOWN

Multicenter Normal Reference Study of Carotid Artery Ultrafast Pulse Wave Velocity (UFPWV)

Lead Sponsor:

Shengjing Hospital

Collaborating Sponsors:

SuperSonic Imagine

Conditions:

Carotid Artery Diseases

Healthy Volunteers

Eligibility:

All Genders

18-79 years

Brief Summary

To establish the range of BS and ES (m/s) of normal carotid artery by using ultrafast pulse wave velocity (UFPWV), and to explore the influencing factors.

Detailed Description

With the gradual aging of Chinese population and continuous development of economy and society, the incidence of cardiovascular disease and the number of patients have increased rapidly. The National ...

Eligibility Criteria

Inclusion

  • Han nationality
  • Age between 18 and 79 years old
  • Normal body mass index (18-25 kg/m2)
  • Normal blood pressure (139-90/89-60 mmHg)
  • No history of cardiovascular disease or respiratory diseases
  • Physical examination reveals no abnormalities in cardiovascular and respiratory systems
  • Normal blood glucose, blood lipid and electrocardiogram (ECG)
  • Echocardiography shows no structural heart disease and normal cardiac function
  • Normal carotid ultrasound
  • No history of cardiovascular drug use

Exclusion

  • Heart valve regurgitation with clinical significance or moderate symptom and above
  • Respiratory system disease: acute or chronic respiratory disease
  • Endocrine diseases: thyroid disease, diabetes mellitus, aldosteronism, pheochromocytoma, and adrenal cortex dysfunction.
  • Metabolic syndrome
  • Anemia
  • Pregnant or lactating women
  • Abnormal liver function (more than twice the normal upper limit), abnormal renal function (creatinine \> 2 mg/dl), total cholesterol \> 190 mg/dl. If Pro-BNP is detected, Pro-BNP is abnormal or in high limit of normal value.
  • Connective tissue disease
  • Tumor
  • Aortic and peripheral vascular diseases: aortic dilatation, aortic dissection, coarctation of the aorta, polyarteritis, atherosclerosis
  • Daily drinking: liquor greater than 50 ml; red wine more than 100 ml; beer more than 300 ml
  • Professional sportsman
  • The poor quality of ultrasonic images cannot meet parameter measurement and analysis

Key Trial Info

Start Date :

October 1 2017

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 31 2024

Estimated Enrollment :

1200 Patients enrolled

Trial Details

Trial ID

NCT03351127

Start Date

October 1 2017

End Date

December 31 2024

Last Update

May 29 2020

Active Locations (44)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 11 (44 locations)

1

The First Affiliated Hospital of Bengbu Medical College

Bengbu, Anhui, China, 233004

2

Civil Aviation General Hospital

Beijing, Beijing Municipality, China

3

University-Town Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, China, 401331

4

Central Hospital of Chongqing Three Gorges

Chongqing, Chongqing Municipality, China, 404000